These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 12750708

  • 1. Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines.
    Davison K, Côté S, Mader S, Miller WH.
    Leukemia; 2003 May; 17(5):931-40. PubMed ID: 12750708
    [Abstract] [Full Text] [Related]

  • 2. PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
    Li L, Wang J, Ye RD, Shi G, Jin H, Tang X, Yi J.
    J Cell Physiol; 2008 Nov; 217(2):486-93. PubMed ID: 18636556
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Simultaneous and ultrarapid determination of reactive oxygen species and reduced glutathione in apoptotic leukemia cells by microchip electrophoresis.
    Qin J, Ye N, Yu L, Liu D, Fung Y, Wang W, Ma X, Lin B.
    Electrophoresis; 2005 Mar; 26(6):1155-62. PubMed ID: 15706575
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
    Ramos AM, Fernandez C, Amrán D, Esteban D, de Blas E, Palacios MA, Aller P.
    J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
    [Abstract] [Full Text] [Related]

  • 7. Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission.
    Zhu J, Lallemand-Breitenbach V, de Thé H.
    Oncogene; 2001 Oct 29; 20(49):7257-65. PubMed ID: 11704854
    [Abstract] [Full Text] [Related]

  • 8. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
    Zuo L, Li J, Yang Y, Wang X, Shen T, Xu CM, Zhang ZN.
    Ann Hematol; 2004 Dec 29; 83(12):751-8. PubMed ID: 15480664
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Curing APL through PML/RARA degradation by As2O3.
    Lallemand-Breitenbach V, Zhu J, Chen Z, de Thé H.
    Trends Mol Med; 2012 Jan 29; 18(1):36-42. PubMed ID: 22056243
    [Abstract] [Full Text] [Related]

  • 11. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A, Kizaki M, Kawamura C, Matsushita H, Fukuchi Y, Umezawa A, Yamada T, Hata J, Hozumi N, Yamato K, Ito M, Ueyama Y, Ikeda Y.
    Leukemia; 2001 Aug 29; 15(8):1176-84. PubMed ID: 11480559
    [Abstract] [Full Text] [Related]

  • 12. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
    Chelbi-alix MK, Bobé P, Benoit G, Canova A, Pine R.
    Oncogene; 2003 Dec 11; 22(57):9121-30. PubMed ID: 14668793
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide: mechanisms of action.
    Davison K, Mann KK, Miller WH.
    Semin Hematol; 2002 Apr 11; 39(2 Suppl 1):3-7. PubMed ID: 12012315
    [Abstract] [Full Text] [Related]

  • 16. The expression of immediate early gene X-1 (IEX-1) is differentially induced by retinoic acids in NB4 and KG1 cells: possible implication in the distinct phenotype of retinoic acid-responsive and -resistant leukemic cells.
    Arlt A, Minkenberg J, Kocs B, Grossmann M, Kruse ML, Fölsch UR, Schäfer H.
    Leukemia; 2004 Oct 11; 18(10):1646-55. PubMed ID: 15306824
    [Abstract] [Full Text] [Related]

  • 17. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U, Terry NH, Kala SV, Lieberman MW, Story MD.
    Cancer Chemother Pharmacol; 2005 Jun 11; 55(6):511-21. PubMed ID: 15761769
    [Abstract] [Full Text] [Related]

  • 18. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
    Zheng X, Seshire A, Rüster B, Bug G, Beissert T, Puccetti E, Hoelzer D, Henschler R, Ruthardt M.
    Haematologica; 2007 Mar 11; 92(3):323-31. PubMed ID: 17339181
    [Abstract] [Full Text] [Related]

  • 19. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
    Yang CH, Kuo ML, Chen JC, Chen YC.
    Br J Cancer; 1999 Nov 11; 81(5):796-9. PubMed ID: 10555748
    [Abstract] [Full Text] [Related]

  • 20. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R, Saulle E, Militi S, Sposi NM, Gualtiero M, Mauro N, Mancini M, Diverio D, Lo Coco F, Peschle C, Testa U.
    Leukemia; 2003 Jan 11; 17(1):98-113. PubMed ID: 12529666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.